Product Details

Abilify Maintena

Aripiprazole
300 mg/Vial
Powder for Prolonged Release Injectable Suspension
Vial Pack

DIN/PIN/NPN

02420864

Manufacturer

Otsuka Pharmaceutical Co. Ltd.

Formulary Listing Date

2015-07-29  

Unit Price

487.2002

Amount MOH Pays

487.2002

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Aripiprazole 300 mg/Vial Powder for Prolonged Release Injectable Suspension in Vial: For the maintenance treatment of schizophrenia in patients who are stabilized on oral aripiprazole who have: A history of non-adherence; AND one of the following: a) Inadequate control or significant side-effects from two or more formulary oral antipsychotic medications, including at least one atypical agent; OR b) Inadequate control or significant side-effects from one or more conventional depot antipsychotic agents.

ATC Code

N05AX12

Interchangeable Products

NO  

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph